Non-invasive positron emission tomography (PET) imaging that targets TILs has shown promise in predicting clinical outcomes of ICB, with increased accumulation of CD8 + T cells as a predictor of tumor regression [8]. The gene discussed is CD8A; the disease is neoplasm.